S

AN FRANCISCO — Senator Bernie Sanders is “a communist,” if you ask Donald Trump. And the president-elect has “dangerous and un-American” ideas for the future of the country, according to Sanders.

But both agree on at least one thing: The pharmaceutical industry is “getting away with murder.”

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Trump is making those statements just because he knows that in his new position he (or friends/family) can profit by sending stocks down periodically. Buy them just after the announcement and sell them weeks later when scare has passed

  • Many people and patients also want to expand the debate, scrutiny and action to expand medical device safety. Why not prescreen people to determine if device materials are “right for you” before being installed? https://www.statnews.com/2016/12/21/medical-devices-safety-congress/. It’s a pretty simple concept.

    Payers and the press should pay more attention. Not only will the outcomes be better health and lower health and long-term care costs, but this will reduce the need for drugs and lifetime medication management to treat the conditions and illnesses that result from immune reactivity to medical and dental materials not “right for you.” This is not uncommon, but often overlooked.

  • Around half the purported cost of developing a drug in the U.S. is spent on advertising, rather than fundamental research. Imagine the cost-savings if the money wasted on ads that no one bothers to read were dramatically cut.

    • indeed, in Europe, drugs advertising is forbidden. And agree, that the idea of high prices = more research is just poppycock. The vast majority of money is spent in lobbying, bribing and advertising

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy